Showing results (161-170 of 175) with videos related to

Sort By:
Pageof 18
Frontiers in Oncology|August 29, 2022
Prognostic significance of CNSL at diagnosis of childhood B-cell acute lymphoblastic leukemia: A report from the South China Children's Leukemia GroupLu-Hong Xu, Xu Geng, Ning Liao, et al.
Blood|March 11, 2026
A low- versus standard-dose regimen as induction for pediatric AML: a multicenter, randomized noninferiority trialLi Gao, Xiaowen Zhai, Ningling Wang, et al.
Annals of Translational Medicine|November 26, 2015
National consensus in China on diagnosis and treatment of patients with advanced breast cancerBinghe Xu, Xichun Hu, Zefei Jiang, et al.
Therapeutic Advances in Medical Oncology|November 5, 2020
MONARCH plus: abemaciclib plus endocrine therapy in women with HR+/HER2- advanced breast cancer: the multinational randomized phase III studyQing Yuan Zhang, Tao Sun, Yong Mei Yin, et al.
Frontiers in Oncology|April 15, 2022
A Nomogram for Predicting Event-Free Survival in Childhood Acute Lymphoblastic Leukemia: A Multicenter Retrospective StudyYun-Yan He, Xiao-Jing Wu, Dun-Hua Zhou, et al.
Annals of Hematology|October 10, 2025
A multicenter study on the prognostic value of prednisone response in pediatric acute lymphoblastic leukemiaJia-Tong Dai, Yun-Yan He, Ya-Ting Zhang, et al.
Cancer|July 26, 2020
Chinese expert consensus on the clinical diagnosis and treatment of advanced breast cancer (2018)Binghe Xu, Xichun Hu, Jifeng Feng, et al.
Oncology Letters|May 29, 2018
Multicenter cross-sectional screening of the BRCA gene for Chinese high hereditary risk breast cancer populationsHongyi Wei, Minghao Wang, Jianghua Ou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2021
Arsenic Combined With All-Trans Retinoic Acid for Pediatric Acute Promyelocytic Leukemia: Report From the CCLG-APL2016 Protocol StudyHuyong Zheng, Hui Jiang, Shaoyan Hu, et al.
International Journal of Cancer|May 13, 2018
Germline mutations in 40 cancer susceptibility genes among Chinese patients with high hereditary risk breast cancerJun-Yan Li, Ruilin Jing, Hongyi Wei, et al.
Pageof 18